The Scientist

» biotech

Most Recent

image: Opinion: Preparing for Potential Disasters

Opinion: Preparing for Potential Disasters

By | January 25, 2017

How to increase the resiliency of biotechnology organizations in the face of emergency risks

0 Comments

On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: Another CRISPR Biotech Goes Public

Another CRISPR Biotech Goes Public

By | September 12, 2016

CRISPR Therapeutics, the company started by a pioneer of the gene editing technology, plans to raise $90 million from an initial public offering.

0 Comments

image: That Other CRISPR Patent Dispute

That Other CRISPR Patent Dispute

By | August 31, 2016

The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

1 Comment

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

0 Comments

image: Theranos CEO Presents New Device

Theranos CEO Presents New Device

By | August 2, 2016

The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.

0 Comments

image: The Growth of Iowa Biotech

The Growth of Iowa Biotech

By | August 1, 2016

The state’s industry draws inspiration from medicine as well as agriculture.

1 Comment

image: 23andMe Markets Genome Kits to Researchers

23andMe Markets Genome Kits to Researchers

By | July 14, 2016

Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.

0 Comments

image: Jennifer Lawrence to Star in Theranos Movie

Jennifer Lawrence to Star in Theranos Movie

By | June 13, 2016

The actress will portray the troubled blood testing startup’s founder, Elizabeth Holmes. 

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS